Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Standard Biotools (LAB) over the last 17 years, with Q3 2025 value amounting to $946000.0.

  • Standard Biotools' Change in Account Payables rose 14313.73% to $946000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 11572.55%. This contributed to the annual value of -$13.0 million for FY2024, which is 90191.59% down from last year.
  • According to the latest figures from Q3 2025, Standard Biotools' Change in Account Payables is $946000.0, which was up 14313.73% from $1.4 million recorded in Q2 2025.
  • In the past 5 years, Standard Biotools' Change in Account Payables ranged from a high of $3.4 million in Q1 2021 and a low of -$10.3 million during Q1 2024
  • Over the past 5 years, Standard Biotools' median Change in Account Payables value was -$131000.0 (recorded in 2021), while the average stood at -$582526.3.
  • In the last 5 years, Standard Biotools' Change in Account Payables crashed by 1226666.67% in 2021 and then soared by 51137.44% in 2023.
  • Quarter analysis of 5 years shows Standard Biotools' Change in Account Payables stood at -$131000.0 in 2021, then crashed by 873.28% to -$1.3 million in 2022, then skyrocketed by 264.86% to $2.1 million in 2023, then crashed by 104.19% to -$88000.0 in 2024, then surged by 1175.0% to $946000.0 in 2025.
  • Its Change in Account Payables stands at $946000.0 for Q3 2025, versus $1.4 million for Q2 2025 and -$578000.0 for Q1 2025.